Stroke in systemic lupus erythematosus and antiphospholipid syndrome: risk factors, clinical manifestations, neuroimaging, and treatment.

about

The risk of ischaemic stroke in primary antiphospholipid syndrome patients: a prospective study.The cutaneous manifestations are significantly related to cerebrovascular in a Serbian cohort of patients with Hughes syndrome.

P2860

Q45873735-21BB9AFE-4E9F-4412-926D-6E247E5F694F Q48509173-B89BC24E-A8F8-48ED-AF98-106E3608C027

P2860

Stroke in systemic lupus erythematosus and antiphospholipid syndrome: risk factors, clinical manifestations, neuroimaging, and treatment.

Item

http://www.wikidata.org/entity/Q38844621

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Stroke in systemic lupus eryth ...... , neuroimaging, and treatment.

@en

type

Item

label

Stroke in systemic lupus eryth ...... , neuroimaging, and treatment.

@en

prefLabel

Stroke in systemic lupus eryth ...... , neuroimaging, and treatment.

@en

P1476

Stroke in systemic lupus eryth ...... , neuroimaging, and treatment.

@en

P2093

C E M Rodrigues

http://www.w3.org/2001/XMLSchema#string

F M Maia

http://www.w3.org/2001/XMLSchema#string

L C D de Amorim

http://www.w3.org/2001/XMLSchema#string

P2860

Stroke in systemic lupus erythematosus: a meta-analysis of population-based cohort studies

Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke

A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS)

The diagnosis and clinical management of the neuropsychiatric manifestations of lupus.

The ischemic penumbra: operationally defined by diffusion and perfusion MRI.

Cerebral manifestations in the antiphospholipid (Hughes) syndrome.

EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics.

Sneddon syndrome with or without antiphospholipid antibodies. A comparative study in 46 patients.

The mystery of Sneddon syndrome: relationship with antiphospholipid syndrome and systemic lupus erythematosus.

The Euro-Phospholipid project: epidemiology of the antiphospholipid syndrome in Europe.

P304

529-536

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0961203316688784

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28394226

http://www.w3.org/2001/XMLSchema#string

P921

neuroimaging

Stroke in systemic lupus erythematosus and antiphospholipid syndrome: risk factors, clinical manifestations, neuroimaging, and treatment.

about

P2860

P2860

Stroke in systemic lupus erythematosus and antiphospholipid syndrome: risk factors, clinical manifestations, neuroimaging, and treatment.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921